MyPhoto CEO Shares Experience with COVID-19 in Virtual Conversation
May 12, 2020
CEO Warren Struhl talks about how his company, MyPhoto, is weathering the COVID-19 pandemic
We’re video chatting with MyPhoto CEO Warren Struhl from his home in Boca Raton, Florida. Stay tuned as we discuss how he and his company are handling the COVID-19 pandemic.
“It’s been rough,” he explains. “We’re doing our best to be as upbeat and safe as possible.”
As a small business owner, Warren has pivoted his company to help keep his workers safe while still remaining operational. The MyPhoto team is following all safety protocols, including physical distancing, shift rotations, and mask and glove use.
Beyond MyPhoto’s day-to-day operations, Warren has witnessed a few new photo trends during the pandemic. With families sheltered at home, he is seeing an uptick in users who are interested in organizing all of their photos. In addition, he launched a photo puzzle special, as well as other innovative photo projects.
“As a CEO, I’ve seen a lot,” he says. “But I’ve never seen anything like this. The only advice I can say is stay somewhat calm. It will pass. We don’t know when, but it will. Don’t do anything rash. And communicate with your employees and customers. Whatever information you have, be honest and open. We at MyPhoto will come out of this and we may be stronger than ever after this.”
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.